BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN DRUGS COST U.S. $805 MILLION IN 2021
Dec 7, 2022
Brand Name Drug Companies Continue Raising Prices on Blockbuster Products With… Read More
© 2024 CSRXP- All Rights Reserved
Updates
BIG PHARMA WATCH: MERCK PLOTS TO FURTHER BLOCK COMPETITION AND EXTEND MONOPOLY PRICING ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Dec 2, 2022
Big Pharma Giant Wants New Patents for Formulation Changes That Won’t… Read More
BIG PHARMA WATCH: DRUG COMPANY VERTEX PRICE-GOUGING BRAND NAME CYSTIC FIBROSIS TREATMENTS AND BANKING HUGE PROFITS
Nov 30, 2022
Patient Advocates Warn Access to Egregiously Priced Treatments at Risk Drug… Read More
CSRXP: NEW MOST EXPENSIVE DRUG IN THE WORLD CARRIES PRICE TAG $600,000 HIGHER THAN ESTIMATES FOR A FAIR PRICE
Nov 30, 2022
Hemgenix Pricing Reflects Escalating Big Pharma Trend of Setting Higher and… Read More
CSRXP: OUTRAGEOUS PRICE TAG ON NEW DIABETES DRUG LATEST EXAMPLE OF BIG PHARMA’S OUT-OF-CONTROL LAUNCH PRICES
Nov 21, 2022
Drug Company Sets Nearly $200,000 Price on Newly Approved Treatment for Type 1… Read More
CSRXP APPLAUDS FDA APPROVAL OF SECOND INTERCHANGEABLE BIOSIMILAR FOR INSULIN
Nov 18, 2022
Interchangeable Biosimilars Help Provide Patients with Greater Choice and More… Read More
TWO BIRDS OF A FEATHER: BIG PHARMA COMPANIES EYE MERGER TO UNDERMINE GENERIC COMPETITION TO OPIOID TREATMENTS
Nov 16, 2022
Brand Name Drug Company to Acquire Manufacturer of Narcan as Both Work to… Read More
BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE, AMGEN, ASTRAZENECA
Nov 11, 2022
Big Pharma Giants Notch Expectation-Busting Earnings After Continuing to Hike… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE, SANOFI, ELI LILLY
Nov 4, 2022
Big Pharma Giants Beat Wall Street Expectations After Year of Price Increases,… Read More
BIG PHARMA WATCH: REPRESENTATIVE KATIE PORTER HIGHLIGHTS BIG PHARMA’S OUTRAGEOUS CANCER DRUG LAUNCH PRICES
Nov 3, 2022
New Report Finds Brand Name Drug Companies Increased Prices on New Oncology… Read More
DOSE OF REALITY: NEW STUDY UNDERSCORES BIG PHARMA’S PRICING PRACTICES ARE ABOUT PROFITS, NOT VALUE FOR PATIENTS
Nov 1, 2022
JAMA Analysis Finds No Correlation Between Cancer Drug Prices and… Read More
BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB, NOVARTIS
Oct 28, 2022
New Earnings Reports Show Big Pharma Giants Basking in Massive Profits,… Read More